Epidemiology and clinical features of post-transplant bloodstream infection: An analysis of 222 consecutive liver transplant recipients

Infection and Chemotherapy

Volumn 45, Issue 3, 2013, Pages 315-324

  Kim, Hyun Kyung ^a   Park, Yong Keun ^a   Wang, Hee Jung ^a   Kim, Bong Wan ^a   Shin, So Youn ^a   Lim, Seung Kwan ^a   Choi, Young Hwa ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Bacteremia; Bloodstream infection; Epidemiology; Liver transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; BASILIXIMAB; CEFOPERAZONE PLUS SULBACTAM; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; HEPATITIS B ANTIBODY; METHYLPREDNISOLONE; NEOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; TACROLIMUS; VALACICLOVIR; VANCOMYCIN;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; ADULT; ALCOHOL LIVER CIRRHOSIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CANDIDA; CANDIDEMIA; CATHETER INFECTION; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DEATH; DRUG MEGADOSE; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUNGUS ISOLATION; GRAFT FAILURE; GRAFT RECIPIENT; HEMODIALYSIS; HEPATITIS B; HEPATOBILIARY SYSTEM INFECTION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; KLEBSIELLA PNEUMONIAE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER GRAFT; LIVER GRAFT REJECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; MYCOSIS; OUTCOME ASSESSMENT; PARTIAL HEPATECTOMY; PNEUMOCYSTIS PNEUMONIA; POST TRANSPLANT BLOODSTREAM INFECTION; POSTOPERATIVE COMPLICATION; PSEUDOMONAS; RETRANSPLANTATION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; SURGICAL PATIENT; SURVIVAL RATE; TUMOR RECURRENCE; WOUND INFECTION; YEAST;

EID: 84887561922     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2013.45.3.315     Document Type: Article

References (27)

1. Snydman DR. Infection in solid organ transplantation. Transpl Infect Dis 1999;1:21-8.
2. Kim SI, Kim YJ, Jun YH, Wie SH, Kim YR, Choi JY, Yoon SK, Moon IS, Kim DG, Lee MD, Kang MW. Epidemiology and risk factors for bacteremia in 144 consecutive living-donorliver transplant recipients. Yonsei Med J 2009;50:112-21.
3. Nah YW, Lee SG, Lee YJ, Park KM, Hwang S, Choi DL, Ahn CS, Park DE, Joo SH, Jeon JY, Min PC. Infection after adult-to-adult living donor liver transplantation. J Korean Soc Transplant 2001;15:93-105.
4. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995;21:1328-36.
5. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000;6:54-61.
6. Iida T, Kaido T, Yagi S, Yoshizawa A, Hata K, Mizumoto M, Mori A, Ogura Y, Oike F, Uemoto S. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 2010;16:1379-85.
7. Kawecki D, Chmura A, Pacholczyk M, Lagiewska B, Adadynski L, Wasiak D, Malkowski P, Rokosz A, Sawicka-Grzelak A, Szymanowska A, Swoboda-Kopec E, Wroblewska M, Rowinski W, Durlik M, Luczak M. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc 2007;39:2816-21.
8. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004;10:844-9.
9. Shi SH, Kong HS, Xu J, Zhang WJ, Jia CK, Wang WL, Shen Y, Zhang M, Zheng SS. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis 2009;11:405-12.
10. Kim YJ, Kim SI, Ko SH, Jeon YH, Moon IS, Kim DG, Lee MD, Kang MW. Epidemiological data on antibiotic-resistant bacteria isolated in liver transplant recipients. J Korean Soc Transplant 2008;22:203-8.
11. Choe EK, Suh KS, Cho JY, Lee HW, Cho EH, Yi NJ, Lee KU. Clinical significance of vancomycin resistant enterococcus in liver transplantation. J Korean Soc Transplant 2006;2:241-7.
12. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
13. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
14. Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Bloodstream infection after living donor liver transplantation. Scand J Infect Dis 2008;40:509-16.
15. Bert F, Larroque B, Paugam-Burtz C, Janny S, Durand F, Dondero F, Valla DC, Belghiti J, Moreau R, Nicolas-Chanoine MH. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl 2010;16:393-401.
16. Li C, Mi K, Wen Tf, Yan Ln, Li B, Yang Jy, Xu Mq, Wang WT, Wei Yg. A learning curve for living donor liver transplantation. Dig Liver Dis 2012;44:597-602.
17. Kim BW, Bae BK, Lee JM, Won JH, Park YK, Xu WG, Wang HJ, Kim MW. Duct-to-duct biliary reconstructions and complications in 100 living donor liver transplantations. Transplant Proc 2009;41:1749-55.
18. Hampe T, Dogan A, Encke J, Mehrabi A, Schemmer P, Schmidt J, Stiehl A, Sauer P. Biliary complications after liver transplantation. Clin Transplant 2006;20 (Suppl 17):93-6.
19. Linares L, García-Goez JF, Cervera C, Almela M, Sanclemente G, Cofán F, Ricart MJ, Navasa M, Moreno A. Early bacteremia after solid organ transplantation. Transplant Proc 2009;41:2262-4.
20. Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samel C, Barbagallo S, Arentzen J, Lautenbach E. Reemergence of gram-negative health care-associated bloodstream infections. Arch Intern Med 2006;166:1289-94.
21. Lee SO, Kang SH, Abdel-Massih RC, Brown RA, Razonable RR. Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl 2011;17:733-41.
22. Kim YJ, Yoon JH, Kim SI, Hong KW, Kim JI, Choi JY, Yoon SK, You YK, Lee MD, Moon IS, Kim DG, Kang MW. High mortality associated with Acinetobacter species infection in liver transplant patients. Transplant Proc 2011;43:2397-9.
23. Kim YJ, Kim SI, Hong KW, Kim YR, Park YJ, Kang MW. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci 2012;27:471-5.
24. Faenza S, Santoro A, Mancini E, Pareschi S, Siniscalchi A, Zanzani C, Pinna AD. Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation.Transplant Proc 2006;38:1141-2.
25. Nieto-Rodriguez JA, Kusne S, Mañez R, Irish W, Linden P, Magnone M, Wing EJ, Fung JJ, Starzl TE. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 1996;223:70-6
26. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 2007;59:401-6.
27. Waki K, Sugawara Y, Tamura S, Mieno MN, Yamashiki N, Kadowaki T, Kokudo N. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data. Transplantation 2011;92:809-14.